Effect of total treatment time on progression-free and overall survival in cervix carcinoma

被引：0
|
作者：
Delaloye, JF
Coucke, PA
Pampallona, S
DeGrandi, P
机构：
[1] CHU VAUDOIS,DEPT OBSTET & GYNECOL,CH-1011 LAUSANNE,SWITZERLAND
[2] CHU VAUDOIS,DEPT RADIOONCOL,CH-1011 LAUSANNE,SWITZERLAND
来源：
EUROPEAN JOURNAL OF CANCER | 1995年 / 31A卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1172 / 1172
页数：1
相关论文
共 50 条
  • [1] Effect of total treatment time on event-free survival in carcinoma of the cervix
    Delaloye, JF
    Coucke, PA
    Pampallona, S
    DeGrandi, P
    GYNECOLOGIC ONCOLOGY, 1996, 60 (01) : 42 - 48
  • [2] ANALYSIS OF THE CORRELATION OF TIME TO TREATMENT FAILURE WITH OVERALL SURVIVAL VERSUS CORRELATION OF PROGRESSION-FREE SURVIVAL WITH OVERALL SURVIVAL
    Gibson, G. D.
    Henegan, J. C.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2022, 70 (02) : 548 - 548
  • [3] Overall Survival and Progression-Free Survival of Patients Following Luspatercept Treatment in the MEDALIST Trial
    Santini, Valeria
    Fenaux, Pierre
    Zeidan, Amer M.
    Komrokji, Rami S.
    Buckstein, Rena
    Oliva, Esther Natalie
    Ha, Xianwei
    Miteva, Dimana
    Yucel, Aylin
    Nadal, Jose Alberto
    Platzbecker, Uwe
    BLOOD, 2022, 140 : 4079 - 4081
  • [4] Concordance index: Surrogacy of progression-free survival for overall survival
    Fan, Yiwei
    Yin, Guosheng
    CONTEMPORARY CLINICAL TRIALS, 2021, 104
  • [5] Progression-free survival (PFS) as a surrogate for overall survival (OS)
    Stewart, David J.
    Bosse, Dominick
    Hilton, John
    Goss, Glenwood
    Fung-Kee-Fung, Michael
    Jonker, Derek
    CANCER RESEARCH, 2018, 78 (13)
  • [6] EVALUATION OF PROGNOSTIC FACTORS OF OVERALL SURVIVAL AND PROGRESSION-FREE SURVIVAL IN PATIENTS WITH HEPATOCELLULAR CARCINOMA (HCC)
    Bramuzzo, I.
    Gerussi, A.
    Maier, S.
    Bianco, C.
    Romanin, A.
    Pasini, C. Laghi
    Barghini, V.
    Scata, L.
    Donnini, D.
    Uzzau, A.
    Vit, A.
    Sechi, L. A.
    Soardo, G.
    DIGESTIVE AND LIVER DISEASE, 2018, 50 (02) : E217 - E217
  • [7] PROGRESSION-FREE SURVIVAL IS A ROBUST SURROGATE ENDPOINT OF OVERALL SURVIVAL IN IMMUNOTHERAPY TRIALS OF HEPATOCELLULAR CARCINOMA
    Cabibbo, Giuseppe
    Celsa, Ciro
    Enea, Marco
    Battaglia, Salvatore
    Rizzo, Giacomo
    Busacca, Anita
    Matranga, Domenica
    Attanasio, Massimo
    Reig, Maria
    Craxi, Antonio
    Camma, Calogero
    HEPATOLOGY, 2020, 72 : 649A - 649A
  • [8] Progression-Free Survival as a Surrogate Endpoint of Overall Survival in Patients With Metastatic Renal Cell Carcinoma
    Halabi, Susan
    Rini, Brian
    Escudier, Bernard
    Stadler, Walter M.
    Small, Eric J.
    CANCER, 2014, 120 (01) : 52 - 60
  • [9] Progression-free survival is a robust surrogate endpoint of overall survival in immunotherapy trials of hepatocellular carcinoma
    Celsa, C.
    Cabibbo, G.
    Enea, M.
    Battaglia, S.
    Rizzo, G. E. M.
    Busacca, A.
    Matranga, D.
    Attanasio, M.
    Reig, M.
    Craxi, A.
    Camma, C.
    DIGESTIVE AND LIVER DISEASE, 2021, 53 : S35 - S35
  • [10] The prediction of progression-free and overall survival in women with an advanced stage of epithelial ovarian carcinoma
    Gerestein, C. G.
    Eijkemans, M. J. C.
    de Jong, D.
    van der Burg, M. E. L.
    Dykgraaf, R. H. M.
    Kooi, G. S.
    Baalbergen, A.
    Burger, C. W.
    Ansink, A. C.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2009, 116 (03) : 372 - 380
12345